EE9700014A - New oral dosage form containing the magnesium salt of omeprazole - Google Patents

New oral dosage form containing the magnesium salt of omeprazole

Info

Publication number: EE9700014A
Authority: EE; Estonia
Prior art keywords: omeprazole; dosage form; oral dosage; magnesium salt; form containing
Prior art date: 1994-07-08

Application number

EE9700014A

Other languages

Estonian (et)

Other versions

EE03378B1 (en

Inventor

Inga Bengtsson Siv

Ingmar L�vgren Kurt

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-08

Filing date

1995-07-03

Publication date

1997-06-16

1995-07-03 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1997-06-16 Publication of EE9700014A publication Critical patent/EE9700014A/en

2001-04-16 Publication of EE03378B1 publication Critical patent/EE03378B1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

EE9700014A 1994-07-08 1995-07-03 Oral dosage form containing magnesium salt of omeprazole EE03378B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9400679		1994-07-08
PCT/SE1995/000816 WO1996001622A1 (en)	1994-07-08	1995-07-03	New oral pharmaceutical formulation containing magnesium salt of omeprazole

Publications (2)

Publication Number	Publication Date
EE9700014A true EE9700014A (en)	1997-06-16
EE03378B1 EE03378B1 (en)	2001-04-16

Family

ID=20393105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9700014A EE03378B1 (en)	1994-07-08	1995-07-03	Oral dosage form containing magnesium salt of omeprazole

Country Status (15)

Country	Link
EP (1)	EP0768872A1 (en)
KR (1)	KR970704426A (en)
BR (1)	BR9508261A (en)
CA (1)	CA2193681A1 (en)
CZ (1)	CZ379596A3 (en)
EE (1)	EE03378B1 (en)
FI (1)	FI970058A0 (en)
HU (1)	HUT78132A (en)
IS (1)	IS4398A (en)
MX (1)	MX9700152A (en)
NO (1)	NO970036L (en)
NZ (1)	NZ289958A (en)
PL (1)	PL181265B1 (en)
SK (1)	SK166096A3 (en)
WO (1)	WO1996001622A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9500478D0 (en) *	1995-02-09	1995-02-09	Astra Ab	New pharmaceutical formulation and process
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5900258A (en) *	1996-02-01	1999-05-04	Zeolitics Inc.	Anti-bacterial compositions
SI9700186B (en)	1997-07-14	2006-10-31	Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D.	Novel pharmaceutical preparation with controlled release of active healing substances
US6174548B1 (en)	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
SE9704870D0 (en) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulation I
SE9704869D0 (en) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulaton II
US6733778B1 (en)	1999-08-27	2004-05-11	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
SE9802973D0 (en)	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
US6316020B1 (en) *	1999-08-26	2001-11-13	Robert R. Whittle	Pharmaceutical formulations
EP1133987A1 (en) *	2000-03-09	2001-09-19	Ian Whitcroft	Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor
AU3762801A (en) *	2000-03-09	2001-09-17	Andrew Ilchyshyn	Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor
EP2596791B1 (en)	2002-10-16	2015-04-01	Takeda Pharmaceutical Company Limited	Stable solid preparations
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1755566A2 (en) *	2004-06-15	2007-02-28	Teva Pharmaceutical Industries Ltd	Stable pharmaceutical formulations of benzimidazole compounds
CN105106168B (en) *	2015-08-19	2018-03-06	德州德药制药有限公司	A kind of esomeprazole magnesium intestines capsule and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
JPH0768125B2 (en) *	1988-05-18	1995-07-26	エーザイ株式会社	Oral formulation of acid labile compounds
SE9302396D0 (en) *	1993-07-09	1993-07-09	Ab Astra	A NOVEL COMPOUND FORM
SE9302395D0 (en) *	1993-07-09	1993-07-09	Ab Astra	NEW PHARMACEUTICAL FORMULATION

1995
- 1995-07-03 MX MX9700152A patent/MX9700152A/en unknown
- 1995-07-03 WO PCT/SE1995/000816 patent/WO1996001622A1/en not_active Application Discontinuation
- 1995-07-03 BR BR9508261A patent/BR9508261A/en not_active Application Discontinuation
- 1995-07-03 CA CA002193681A patent/CA2193681A1/en not_active Abandoned
- 1995-07-03 EE EE9700014A patent/EE03378B1/en not_active IP Right Cessation
- 1995-07-03 HU HU9700039A patent/HUT78132A/en unknown
- 1995-07-05 KR KR1019970700059A patent/KR970704426A/en not_active Application Discontinuation
- 1995-07-05 EP EP95926067A patent/EP0768872A1/en not_active Withdrawn
- 1995-07-05 SK SK1660-96A patent/SK166096A3/en unknown
- 1995-07-05 PL PL95318464A patent/PL181265B1/en unknown
- 1995-07-05 CZ CZ963795A patent/CZ379596A3/en unknown
- 1995-07-05 NZ NZ289958A patent/NZ289958A/en unknown
1996
- 1996-12-17 IS IS4398A patent/IS4398A/en unknown
1997
- 1997-01-06 NO NO970036A patent/NO970036L/en not_active Application Discontinuation
- 1997-01-07 FI FI970058A patent/FI970058A0/en unknown

Also Published As

Publication number	Publication date
WO1996001622A1 (en)	1996-01-25
NZ289958A (en)	1998-09-24
AU2994795A (en)	1996-02-09
HUT78132A (en)	2000-06-28
FI970058A (en)	1997-01-07
IS4398A (en)	1996-12-17
FI970058A0 (en)	1997-01-07
SK166096A3 (en)	1997-09-10
AU695723B2 (en)	1998-08-20
NO970036D0 (en)	1997-01-06
HU9700039D0 (en)	1997-02-28
NO970036L (en)	1997-01-06
EE03378B1 (en)	2001-04-16
PL181265B1 (en)	2001-06-29
CA2193681A1 (en)	1996-01-25
MX9700152A (en)	1997-04-30
EP0768872A1 (en)	1997-04-23
KR970704426A (en)	1997-09-06
CZ379596A3 (en)	1997-08-13
PL318464A1 (en)	1997-06-09
WO1996001622A8 (en)	1999-12-23
BR9508261A (en)	1997-12-23

Publication	Publication Date	Title
EE9600118A (en)	1997-04-15	New oral pharmaceutical dosage form
EE9700014A (en)	1997-06-16	New oral dosage form containing the magnesium salt of omeprazole
EE9700363A (en)	1998-06-15	New pharmaceutical composition with anesthetic effect
EE9900441A (en)	2000-04-17	Pharmaceutical composition for oral administration of the N-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates
NO20006630L (en)	2001-02-26	Pharmaceutical composition for the treatment of diabetes
HUP9701694A3 (en)	2004-03-01	Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
DZ1876A1 (en)	2002-02-17	Medicines for oral administration.
FR2775596B1 (en)	2004-12-24	NEW PHARMACEUTICAL COMPOSITIONS
FR2705566B1 (en)	1996-04-05	New pharmaceutical compositions.
EE200000395A (en)	2002-02-15	Oral pharmaceutical pulsatile dosage form
EE200100495A (en)	2002-12-16	Carbohydrate-substituted 1,4-benzothiazepine-1,1-dioxide derivatives, process for their preparation, use of the compounds and medicament containing them
EE9900540A (en)	2000-06-15	Omeprazole dosage form
NO992692L (en)	1999-12-06	Nefadozone dosage form
EE200000022A (en)	2000-10-16	New dosage form
NO20005179D0 (en)	2000-10-13	Drug treatment
FI941447A (en)	1994-10-01	Oral ubidecarenone preparations for capsule use
NO20012727D0 (en)	2001-06-01	3,4,5-trisubstituted arylnitron compounds and pharmaceutical compositions containing the same
DK0582897T3 (en)	1997-12-01	Workspace lamp for the medical, especially dental practice
DK0582900T3 (en)	1997-12-22	Workspace lamp for the medical, especially dental practice
NO20002439D0 (en)	2000-05-11	New oral dosage forms for carvediol
NO20013145D0 (en)	2001-06-22	Use of Na-H exchange inhibitors for the preparation of drugs
FI964212A (en)	1996-10-18	X-ray contrast compositions containing pharmaceutically acceptable clays
FR2779145B1 (en)	2004-07-30	NEW PHARMACEUTICAL COMPOSITIONS
NO20005386D0 (en)	2000-10-26	Use of NMDA antagonists for the treatment of irritable bowel syndrome
ITMI950120A0 (en)	1995-01-25	PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2003-04-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20020703